Progression of chronic renal disease

American Journal of Kidney Diseases

Volumn 41, Issue 3 SUPPL. 1, 2003, Pages

  Klahr, Saulo ^a   Morrissey, Jeremiah ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Angiotensin II; Nuclear factor B (NF B); Transforming growth factor 1 (TGF 1); Tumor necrosis factor (TNF )

Indexed keywords

ANGIOTENSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE COURSE; FIBROSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; KIDNEY FUNCTION; METABOLIC ACIDOSIS; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN DIET; PROTEIN EXPRESSION; PROTEINURIA; RECEPTOR UPREGULATION;

EID: 0037374219     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50074     Document Type: Conference Paper

References (23)

1. Klahr S, Morrissey JJ: The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int Suppl 75:S7-S14, 2000
2. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
3. Sharma K, Ziyadeh FN, Alzahabi B, et al: Increased renal production of transforming growth factor-beta 1 in patients with type II diabetes mellitus. Diabetes 46:854-859, 1997
4. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ligation. Kidney Int 44:313-321, 1993
5. Fukuda K, Yoshitomi K, Yanagida T, Tokumoto M, Hirakata H: Quantification of TGF-betal mRNA along rat nephron in obstructive nephropathy. Am J Physiol Ren Physiol 281:F513-F521, 2001
6. Isaka Y, Tsujie M, Ando Y, et al: Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58:1885-1892, 2000
7. Guo G, Morrissey JJ, McCracken R, et al: Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol 280:F777-F785, 2001
8. Morrissey JJ, Klahr S: Transcription factor NF-κB regulation of renal fibrosis. Semin Nephrol 18:603-611, 1998
9. Barnes PJ, Karin M: Nuclear factor-kappa: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
10. Morrissey JJ, Klahr S: Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction. Kidney Int 52:926-933, 1997
11. Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC: Macrophages, monocyte peptide-1, and TGF-betal in experimental hydronephrosis. Am J Physiol 266: F926-F933, 1994
12. Johnson TS, Griffin M, Thomas GL, et al: The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 99:2950-2960, 1997
13. Strutz, F, Okada H, Lo CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
14. Li J, Brazier AR: Angiotensinogen gene activation by angiotensin II is mediated by the Rel A (nuclear factor-kappaB p65) transcription factor: One mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10:252-264, 1996
15. Klahr S, Morrissey JJ: Angiotensin II and gene expression in the kidney. Am J Kidney Dis 31:171-176, 1998
16. Ricardo SK, Ding G, Eufemio M, Diamond JR: Antioxidant expression in experimental hydronephrosis: Role of mechanical stretch and growth factors. Am J Physiol Ren Physiol 272:F789-F798, 1997
17. Morrissey JJ, Duan L, Klahr S: N-Acetylcysteine treatment alters nuclear transcription factor activity and monocyte infiltration during ureteral obstruction. J Am Soc Nephrol 7:1830A, 1996 (abstr)
18. Chevalier RL, Goyal S, Kim A, Chang AY, Landau D, LeRoith D: Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1. Kidney Int 57:882-890, 2000
19. Mizuno S, Matsumoto K, Nakamura T: Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 59:1304-1314, 2001
20. Yang J, Liu Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13:96-107, 2002
21. Yang J, Dai C, Liu Y: Correspondence: Y. Li. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther 8:1470-1479, 2001
22. Hruska KA, Guo G, Wozniak M, et al: Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Ren Physiol 279:F130-F143, 2000
23. Morrissey JJ, Hruska K, Guo G, Wang S, Klahr S: Bone morphogenetic protein-7 (BMP-7) improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13:S14-S21, 2002 (suppl 1)